Press Releases

• One in twenty dollars spent in 2030 could be on counterfeit products
• Corsearch launches Corsearch Zeal technology to empower brand owners to protect IP in the face of this challenge

LONDON--(BUSINESS WIRE)-- Corsearch, leading provider of brand protection and trademark solutions, has today shared research predicting that the size of the global trade in counterfeit goods could reach $1.79 trillion by 2030, a 75% increase from that of 2023 and a growth 3.6... (continue reading...)

SINGAPORE, May 16, 2024 /PRNewswire/ -- OKX, a leading Web3 technology company, has issued updates for May 16, 2024.

OKX Launches Cryptopedia Season 18, Offering Users Up to USD200,000 in BDXN Tokens for Completing Bondex-Related Quests

OKX today announced the launch of season 18 of Cryptopedia, a learn-to-earn platform, giving eligible users the... (continue reading...)

BANGKOK, May 16, 2024 /PRNewswire/ -- Mr. Narongsak Jivakanun (Second from left), CEO of PTT Global Chemical Public Company Limited (GC) presided over the signing ceremony and extended his congratulations to Krungthai Bank and NatureWorks - a joint venture of GC and a leading manufacturer of polylactic acid (PLA) biopolymers made from renewable resources. This is the historic financial support from Krungthai Bank PCL, Thailand's third largest bank, to optimize the... (continue reading...)

NEW YORK, May 16, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a securities purchase agreement with certain institutional investors, providing for the purchase and sale of 380,968 shares of common stock and pre-funded warrants to purchase... (continue reading...)

REDWOOD CITY, Calif., May 16, 2024 /PRNewswire/ -- Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash, with potential for an additional milestone payment.